ATE67666T1 - Verwendung von sulfomucopolysacchariden zur therapeutischen behandlung von krankheiten des alzheimertyps. - Google Patents

Verwendung von sulfomucopolysacchariden zur therapeutischen behandlung von krankheiten des alzheimertyps.

Info

Publication number
ATE67666T1
ATE67666T1 AT88201047T AT88201047T ATE67666T1 AT E67666 T1 ATE67666 T1 AT E67666T1 AT 88201047 T AT88201047 T AT 88201047T AT 88201047 T AT88201047 T AT 88201047T AT E67666 T1 ATE67666 T1 AT E67666T1
Authority
AT
Austria
Prior art keywords
alzheimer
type
sulfomucopolysaccharids
diseases
therapeutic treatment
Prior art date
Application number
AT88201047T
Other languages
English (en)
Inventor
Umberto Cornelli
Thomas A Ban
Original Assignee
Crinos Industria Farmaco
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Crinos Industria Farmaco filed Critical Crinos Industria Farmaco
Application granted granted Critical
Publication of ATE67666T1 publication Critical patent/ATE67666T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
AT88201047T 1987-05-28 1988-05-24 Verwendung von sulfomucopolysacchariden zur therapeutischen behandlung von krankheiten des alzheimertyps. ATE67666T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT20698/87A IT1205042B (it) 1987-05-28 1987-05-28 Composizione farmaceutica ad attivita' terapeutica per il trattamento della demenza senile di tipo alzheimer
EP88201047A EP0293974B1 (de) 1987-05-28 1988-05-24 Verwendung von Sulfomucopolysacchariden zur therapeutischen Behandlung von Krankheiten des Alzheimertyps

Publications (1)

Publication Number Publication Date
ATE67666T1 true ATE67666T1 (de) 1991-10-15

Family

ID=11170725

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88201047T ATE67666T1 (de) 1987-05-28 1988-05-24 Verwendung von sulfomucopolysacchariden zur therapeutischen behandlung von krankheiten des alzheimertyps.

Country Status (8)

Country Link
US (1) US4956347A (de)
EP (1) EP0293974B1 (de)
JP (1) JPS6419021A (de)
AT (1) ATE67666T1 (de)
DE (1) DE3865099D1 (de)
ES (1) ES2040323T3 (de)
GR (1) GR3002802T3 (de)
IT (1) IT1205042B (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5486599A (en) 1989-03-29 1996-01-23 The Board Of Trustees Of The Leland Stanford Junior University Construction and use of synthetic constructs encoding syndecan
US6699968B1 (en) 1989-03-29 2004-03-02 Children's Medical Center Corporation Construction and use of synthetic constructs encoding syndecan
ES2059602T3 (es) * 1989-04-14 1994-11-16 Merz & Co Gmbh & Co Uso de derivados de adamantano para la prevencion y tratamiento de isquemia cerebral.
FR2655267B1 (fr) * 1989-12-04 1992-04-03 Roussel Uclaf Nouveau derive sulfate du galactanne extrait de klebsiella, procede de preparation, application a titre de medicaments et compositions pharmaceutiques le renfermant.
IT1240615B (it) * 1990-04-03 1993-12-17 Mediolanum Farmaceutici Spa Impiego del dermatan solfato nella prevenzione e terapia dell'invecchiamento cerebrale e degli stati di deficit funzionale del sistema nervoso centrale
US5164295A (en) * 1991-03-06 1992-11-17 The Upjohn Company Method for identifying amyloid protein-extracellular matrix protein affinity altering compounds
US5958883A (en) 1992-09-23 1999-09-28 Board Of Regents Of The University Of Washington Office Of Technology Animal models of human amyloidoses
WO1994022437A2 (en) * 1993-03-29 1994-10-13 Queen's University At Kingston Method for treating amyloidosis
US20040208875A1 (en) * 1995-03-15 2004-10-21 Queen's University At Kingston Method for treating amyloidosis
US5505948A (en) * 1993-06-01 1996-04-09 Dermatology Home Products, Inc. Home skin peel composition for producing healthy and attractive skin
CA2260183A1 (en) * 1996-07-09 1998-01-15 Keith A. Crutcher Methods for the treatment of apolipoprotein e related diseases
US6277874B1 (en) * 1996-07-09 2001-08-21 University Of Cincinnati And Apologic, Incorporated Methods for the treatment of apolipoprotein E related diseases
AU9125798A (en) * 1997-08-28 1999-03-16 University Of Washington Specific saccharide compositions and methods for treating alzheimer's disease and other amyloidoses
US20020022657A1 (en) * 1998-02-11 2002-02-21 Francine Gervais Methods for modulating neuronal cell death
IL146143A0 (en) * 1999-04-28 2002-07-25 Univ Kingston Compositions and methods for treating amyloidosis
IT1312107B1 (it) 1999-05-14 2002-04-04 Umberto Cornelli Glicosaminoglicani aventi peso molecolare medio di 2400 d atti altrattamento della demenza senile
US6608042B2 (en) * 2000-03-28 2003-08-19 Aventis Pharma, S.A. Pharmaceutical compositions containing oligosaccharides, the novel oligosaccharides and preparation thereof
ITMI20031023A1 (it) * 2003-05-21 2004-11-22 Umberto Cornelli Glicosaminoglicani aventi peso molecolare medio 2400 d atti al trattamento delle disfunzioni emozionali.
US7414076B2 (en) * 2003-06-23 2008-08-19 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
US20070010573A1 (en) 2003-06-23 2007-01-11 Xianqi Kong Methods and compositions for treating amyloid-related diseases
US7244764B2 (en) * 2003-06-23 2007-07-17 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
US20060074049A1 (en) * 2004-10-05 2006-04-06 Mitchell Krathwohl Use of heparinoids for treatment and prevention of dementia
EP1828111A2 (de) * 2004-11-12 2007-09-05 Neurochem (International) Limited Verfahren und fluorierte zusammensetzungen zur behandlung von amyloidbedingten krankheiten
CN101103018A (zh) * 2004-11-16 2008-01-09 神经化学（国际）有限公司 治疗cns和淀粉样蛋白-相关疾病的化合物
BRPI0519243A2 (pt) * 2004-12-22 2009-01-06 Neurochem Int Ltd mÉtodos e composiÇÕes para tratar doenÇas relacionadas a amilàide
TW200716088A (en) * 2005-04-15 2007-05-01 Neurochem Int Ltd Formulations and methods for treating amyloidosis
WO2006111348A1 (de) * 2005-04-18 2006-10-26 Abbott Gmbh & Co. Kg Verwendung von heparin und heparinderivaten zur modulation des neuritenwachstum-kontrollierenden nogo-rezeptors
MX2008008213A (es) * 2005-12-22 2008-09-03 Neurochem Int Ltd Tratamiento de trastornos renales, nefropatia diabetica y dislipidemias.
DK2089417T3 (en) 2006-10-12 2015-03-23 Bhi Ltd Partnership Methods, Compounds, Compositions and Vehicles for Delivery of 3-Amion-1-Propanesulfonic Acid
CN101730529A (zh) * 2006-12-22 2010-06-09 贝鲁斯健康(国际)有限公司 用于治疗代谢疾病和糖尿病的方法、化合物和组合物
WO2015184231A2 (en) * 2014-05-30 2015-12-03 Kolltan Pharmaceuticals, Inc. Regulators of anaplastic lymphoma kinase and uses thereof
JP2023159833A (ja) * 2022-04-20 2023-11-01 江南化工株式会社 脳機能改善用組成物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3000787A (en) * 1957-11-06 1961-09-19 Crinos Industria Farmaco Heparinoid anticholestrolemic factor
US3007787A (en) * 1960-03-16 1961-11-07 Monsanto Chemicals Butyl xylyl sulfone

Also Published As

Publication number Publication date
EP0293974A1 (de) 1988-12-07
IT8720698A0 (it) 1987-05-28
DE3865099D1 (de) 1991-10-31
EP0293974B1 (de) 1991-09-25
JPS6419021A (en) 1989-01-23
ES2040323T3 (es) 1993-10-16
GR3002802T3 (en) 1993-01-25
IT1205042B (it) 1989-03-10
US4956347A (en) 1990-09-11

Similar Documents

Publication Publication Date Title
ATE67666T1 (de) Verwendung von sulfomucopolysacchariden zur therapeutischen behandlung von krankheiten des alzheimertyps.
ATE79544T1 (de) Zusammensetzungen zur behandlung von hypercholesterinaemie.
DE69233559D1 (de) Osteogenische proteine in der behandlung von metabolischen knochenkrankheiten
ATE258065T1 (de) Behandlung von autoimmun-erkrankungen durch orale verabreichung von autoantigenen
DE3588023D1 (de) Mittel zur Behandlung von Herzerkrankungen.
DE3856594D1 (de) Mittel zur behandlung der alzheimer-krankheit
EP0295721A3 (en) Promotion of healing of meniscal tissue
ATE71629T1 (de) Methylenphosphonalkylphosphinate, pharmazeutische zubereitungen und verfahren zur behandlung abnormalen kalzium- und phosphat-stoffwechsels.
DE3587741D1 (de) Behandlung von Hautkrankheiten.
ATE99171T1 (de) Praeparate zur behandlung von beschwerden der wurzelhaut der zaehne.
GR861803B (en) Novel carbonic acid derivatives method for their preparation their use and medicine containing them
PT88684A (pt) Metodo de tratamento fosfatidilico de doencas virais
DE3778585D1 (de) Herzschrittmacher zur stimulierung des menschlichen herzens.
ZM3087A1 (en) Treatment of diseases caused by retroviruses
ATE77751T1 (de) Mittel zur behandlung von knochenkrankheiten.
FI864570A0 (fi) Terapeutiskt anvaendbar foerening.
DE3778587D1 (de) Herzschrittmacher zur stimulierung des menschlichen herzens.
DE3884895D1 (de) Verwendung von Bezafibrat zur Behandlung von Diabetes.
IT8721115A0 (it) Fitopreparato per la cura di affezioni cutanee.
ATE59780T1 (de) Pharmazeutische zusammensetzung zur behandlung von tumoren.
DE3875016D1 (de) Therapeutikum zur behandlung von aids.
ATE45675T1 (de) Verwendung von interferon gamma (ifn-gamma) zur herstellung von praeparationen zur behandlung rheumatischer erkrankungen.
DK10188D0 (da) Middel til behandling af virussygdomme
JPS5753475A (en) Novel thiazolyl-2-oxamic acid derivative, manufacture and medicine containing same
ATE136776T1 (de) Verwendung von heptastigmin zur behandlung der zerebralen ictus

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee